BIO NMDCAT Conjugated molecules
nmdcat.online July 3, 2026

91. The molecular mechanism of the drug Tunicamycin involves acting as a structural analog of UDP-GlcNAc, thereby inhibiting the enzyme GlcNAc phosphotransferase. The introduction of this drug blocks the very first step of

A. O-linked glycosylation in the Golgi
B. Synthesis of the dolichol-linked oligosaccharide core in N-linked glycosylation
C. Assembly of apolipoproteins onto chylomicrons
D. Wrapping of DNA around the histone nucleoprotein core

📝 Explanation

Tunicamycin blocks the transfer of N-acetylglucosamine-1-phosphate onto dolichol phosphate, halting the assembly of the core sugar chain.

📖 Additional Information

  • O-linked glycosylation in the Golgi
  • Synthesis of the dolichol-linked oligosaccharide core in N-linked glycosylation
  • Assembly of apolipoproteins onto chylomicrons
  • Wrapping of DNA around the histone nucleoprotein core

Tunicamycin blocks the transfer of N-acetylglucosamine-1-phosphate onto dolichol phosphate, halting the assembly of the core sugar chain.

🔗 Share This Question

Categories

View all →